President Trump's government overhaul in annual reports, highlighting risks from tariffs to healthcare reforms.

CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

Valentina Dabos, lead author of the tracker, said in a statement that the consequences of bankruptcies in healthcare "can be ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

DeVaney was named interim president of Caremark's PBM business in December 2024. CVS Health has named Ed DeVaney president of the company’s Caremark pharmacy benefit management business. Named interim ...